购物车
全部删除
您的购物车当前为空
别名 OTX015 (MK 8628/Birabresib), OTX-015, MK-8628
Birabresib (MK-8628) 是一种 BRD2/3/4抑制剂,IC50值为 92 到 112 nM 之间,具有潜在的抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Birabresib (MK-8628) 是一种 BRD2/3/4抑制剂,IC50值为 92 到 112 nM 之间,具有潜在的抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 282 | 现货 | |
| 2 mg | ¥ 398 | 现货 | |
| 5 mg | ¥ 822 | 现货 | |
| 10 mg | ¥ 1,230 | 现货 | |
| 25 mg | ¥ 2,160 | 现货 | |
| 50 mg | ¥ 3,390 | 现货 | |
| 100 mg | ¥ 4,990 | 现货 | |
| 200 mg | ¥ 6,960 | 现货 | |
| 500 mg | ¥ 10,500 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 888 | 现货 |
Birabresib 相关产品
| 产品描述 | Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity. |
| 靶点活性 | BRDs:10-19 nM(EC50) |
| 体外活性 | Birabresib抑制BRD2、BRD3和BRD4与AcH4的结合,IC50值在92至112 nM之间,且抑制多种人类癌细胞系的增长,GI50值在60至200 nM范围内。[1] Birabresib迅速下调c-MYC表达,并在与ALK抑制剂联合使用时,对ALKpos ALCL细胞系显示出协同的抗增殖效应。[2] |
| 体内活性 | OTX015 (p.o.) 在裸鼠体内有效抑制Ty82 BRD-NUT中线癌肿瘤的生长,分别在每日一次100 mg/kg和每日两次10 mg/kg的剂量下,抑制率达到79%和61%。[1] |
| 激酶实验 | |
| 细胞实验 | Effects of OTX015 on cancer cell proliferation are evaluated by incubating human tumor cells for 72 h with increasing concentrations of OTX015 and assessing proliferation using a tetrazolium salt (WST-8)-based colorimetric assay.(Only for Reference) |
| 别名 | OTX015 (MK 8628/Birabresib), OTX-015, MK-8628 |
| 分子量 | 491.99 |
| 分子式 | C25H22ClN5O2S |
| CAS No. | 202590-98-5 |
| Smiles | CC=1C2=C(N3C([C@H](CC(NC4=CC=C(O)C=C4)=O)N=C2C5=CC=C(Cl)C=C5)=NN=C3C)SC1C |
| 密度 | 1.45 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 9.8 mg/mL (19.92 mM), Sonication is recommended. DMSO: 255 mg/mL (518.3 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.07 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容